Production of Human Monoclonal Antibody to X31 Influenza Virus Nucleoprotein

References

1. Callard R. E. 1979; Specific in vitro antibody response to influenza virus by human blood lymphocytes. Nature, London 282:734–736
   [Google Scholar]
2. Crawford D. H. 1981; Lymphomas after cyclosporin A treatment. Transplantation and Clinical Immunology 13: (Proceedings of the Thirteenth International Course) 48–52
   [Google Scholar]
3. Kozbor D., Roder J. C. 1981; Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. Journal of Immunology 127:1275–1280
   [Google Scholar]
4. Kozbor D., Steinitz M., Klein G., Koskimies S., Makela O. 1979; Establishment of anti-TNP antibody producing human lymphoid lines by pre-selection for hapten binding followed by EBV transformation. Scandinavian Journal of Immunology 10:187–194
   [Google Scholar]
5. Lowe J., Hardie D., Jeffens R., Ling N. R., Drysdale P., Richardson P., Raykundabe C., Caty D., Appleby P., Drew R., Maclennan I. C. M. 1981; Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains. Immunology 42:649–659
   [Google Scholar]
6. Miller G., Shope T., Lisco H., Stitt D., Lipman M. 1972; Epstein-Barr virus: transformation, cytopathic changes and viral antigens in squirrel monkey and marmoset leucocytes. Proceedings of the National Academy of Sciences of the United States of America 69:383–387
   [Google Scholar]
7. Naiem M., Gerdes J., Abdulaziz Z., Nash J. R. C., Stein H., Mason D. Y. 1981; Production of monoclonal antibodies for the immunohistological analysis of human lymphoma. In Leukaemia Markers pp 117–121 Edited by Knapp W. London: Academic Press;
   [Google Scholar]
8. Pattengale P. K., Smith R. W., Gerber P. 1973; Selective transformation of B lymphocytes by EB virus. Lancet ii:93–94
   [Google Scholar]
9. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leucocytes in vitro by filtrates of a human leukaemia cell line containing herpes-like virus. International Journal of Cancer 3:857–866
   [Google Scholar]
10. Rosen A., Gergely P., Jondal M., Klein G., Britton S. 1977; Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature, London 267:52–54
    [Google Scholar]
11. Steinitz M., Tamir S. 1982; Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line. European Journal of Immunology 12:126–133
    [Google Scholar]
12. Steinitz M., Klein G., Koskimies S., Makela O. 1977; EB virus induced B lymphocyte cell lines producing specific antibody. Nature, London 269:420–422
    [Google Scholar]
13. Steinitz M., Koskimies S., Klein G., Makela O. 1979; Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr (EBV) transformation. Journal of Clinical and Laboratory Immunology 2:1–7
    [Google Scholar]
14. Steinitz M., Izak G., Cohen S., Ehrenfeld M., Flechner I. 1980; Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature, London 287:443–445
    [Google Scholar]
15. Zanders E. D., Smith C. M., Callard R. E. 1981; A micromethod for the induction and assay of specific in vitro antibody responses by human lymphocytes. Journal of Immunological Methods 47:333–338
    [Google Scholar]